Dr. Raghad Muhsin Abdul-Karim, MD

Dr. Abdul-Karim practices at MyMichigan Medical Center Alpena in Alpena, Michigan, part of MyMichigan Health.

Dr. Abdul-Karim's NPI, 1114207172, was assigned on August 23, 2011. Dr. Abdul-Karim graduated from University of Baghdad College of Medicine in 2003. Dr. Abdul-Karim holds Texas license P8435.

Dr. Abdul-Karim's primary practice is MyMichigan Medical Center Alpena, at 1501 W Chisholm St, Alpena, MI 49707 in Alpena County. The practice phone is (989) 356-7390.

Dr. Abdul-Karim's primary practice is MyMichigan Medical Center Alpena in Alpena, Michigan, part of MyMichigan Health. Dr. Abdul-Karim is also affiliated with Onvida Health Yuma Medical Center. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Abdul-Karim to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdul-Karim practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Abdul-Karim's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Abdul-Karim is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Abdul-Karim's licenses on file in 6 states: Texas, Arizona, Michigan, Ohio, Pennsylvania and Virginia.

Dmand AI lists acute respiratory failure, chronic anemia, deep vein thrombosis (DVT), gastrointestinal bleeding, osteoporosis, pneumonia, purpura and thrombocytopenia and rash among the conditions Dr. Abdul-Karim treats.

CMS data shows 831 Medicare services from Dr. Abdul-Karim across 3 procedure codes in 2024, all of them office visits, for 304 Medicare patients. Medicare paid $59,106 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 304 Medicare patients who saw Dr. Abdul-Karim in 2024. The largest group is 75 to 84, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdul-Karim's median patient age at 68, with 57% women.

In 2024, Dr. Abdul-Karim wrote 1,070 Medicare Part D claims for 251 patients. 82% of them were for generic drugs. CMS names the drug for 807 of them, across 21 drugs with 11 or more claims each, at $1,267,406 in total drug cost. In 2023, CMS named 404 claims across 15 drugs.

Dr. Abdul-Karim accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Abdul-Karim in 2017. Dr. Abdul-Karim's most frequent co-author is Charles Lance Cowey, MD.

CMS Open Payments shows 110 general payments to Dr. Abdul-Karim from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Eisai Inc. paid the most, $2,045. It also lists 10 research payments totaling $33,266 from 2023 to 2024.

Dr. Abdul-Karim graduated from University of Baghdad College of Medicine in 2003.

Dr. Abdul-Karim is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.